Stock Market Blog
Daily stock market analysis, trade alerts, and trading education from Ross Givens and the Traders Agency team.
Emera to Acquire Canadian Utilities and ATCO in $14.3 Billion All-Share Deal, Spinning Off New ATCO
Emera, Canadian Utilities and ATCO announced a $14.3 billion all-share merger with fixed exchange ratios and a spinoff of ATCO's industrial operations into New ATCO, targeting a 2027 close.
Google and Constellation Strike Two-Part Nuclear Deal: 20-Year PPA Funds 890 MW of Reactor Uprates, Plus 15-Year, 2,700 MW Supply Pact
Google and Constellation announced a 20-year PPA funding uprates at 11 nuclear units to add 890 MW to PJM, plus a separate 15-year, 2,700 MW supply deal; Constellation shares rose 7.2% premarket, per Seeking Alpha.
Saudi-Backed Yemeni Forces Claim Mokha and Bab el-Mandeb Coast; Houthis Deny City's Fall, Say They Hit Saudi Airports and an Aramco Refinery
Yemen's government says its Saudi-backed forces retook Mokha and coast near Bab el-Mandeb, per CNBC, Reuters via RTHK and Seeking Alpha. Houthis call the claim baseless and say they struck Saudi airports and an Aramco refinery. Brent traded 0.3% lower at $100.12.
CFTC Advances Federal 'Crypto Asset Market' Registration for Leveraged Retail Trading
The CFTC published an advance notice of proposed rulemaking on Oct. 5, 2026 creating an optional federal 'crypto asset market' registration for leveraged, margined or financed retail crypto trading, with a 60-day comment window.
Huawei and Qualcomm Sign Multi-Year Patent Cross-License Covering 5G, AI and Compute Technologies
Huawei and Qualcomm announced a multi-year patent cross-license covering 5G, compute, AI and networking, plus Qualcomm's purchase of certain Huawei U.S. patents, pending regulatory approval.
Stock Market Today: Materials Leads While S&P 500 Advances
Materials led the session while the S&P 500 advances. See the validated market scorecard, sector performance, and what traders are watching next.
Vaxcyte Shares Jump About 30% as VAX-31 Clears All Primary Endpoints in Pivotal OPUS-1 Trial
Vaxcyte shares jumped about 30% after VAX-31 met both primary endpoints in the pivotal Phase 3 OPUS-1 trial; two serotype comparisons against Capvaxive missed the stricter bar, with a BLA filing planned for the first half of 2028.
Alector Licenses Preclinical Parkinson's Program AL050 to Genentech in Deal Worth Up to $1.27 Billion
Alector licensed preclinical Parkinson's program AL050 to Roche's Genentech for $100 million upfront and up to $1.17 billion in milestones, with shares jumping sharply on the news.
Ellison and Kreiz Name Skydance Leadership Team a Day Before Paramount-Warner Bros. Discovery Deal Closes
David Ellison and Ynon Kreiz named Skydance's CEO leadership team a day before the Paramount-Warner Bros. Discovery deal's expected Oct. 6 close, with Casey Bloys, George Cheeks and JB Perrette in top content and business roles.
Skyworks Completes Qorvo Combination, Finalizing $32.50-Plus-Stock Terms
Reports say Skyworks completed its combination with Qorvo on October 5, 2026, with Qorvo holders receiving $32.50 cash plus 0.960 Skyworks shares, a 63/37 ownership split and a $500 million-plus annual cost-synergy target.
Flávio Bolsonaro Edges Lula in Brazil's First Round, Setting Up Oct. 25 Runoff as Markets Rally
Flávio Bolsonaro led Brazil's first round with 47.3% to Lula's 44.8%, forcing an Oct. 25 runoff, as Petrobras, Vale, Nubank and XP rose in Monday premarket trading.
Cenovus Energy Agrees to Buy Athabasca Oil for C$12 a Share in C$5.7 Billion Cash-and-Stock Deal
Cenovus will acquire Athabasca Oil for C$12 a share or 0.264 Cenovus shares in a deal valued at about C$5.7 billion, adding roughly 45 MBOE/d, with closing targeted for December 2026.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
